BIRC5 and cancer: Survivin is highly expressed in most types of human and canine malignant neoplasms, including melanoma and osteosarcoma [9]–[13], but is expressed at very low levels in normal cells and benign tumors, with the exception of hematopoietic progenitor cells and fibroblasts [14]–[18].